戈舍瑞林治疗绝经前转移性乳腺癌患者
Zoladex in the treatment of premenopausal metastatic breast cancer patients.
作者信息
Kaufmann M
机构信息
Universitats-Frauenklinik, Heidelberg, FRG.
出版信息
Horm Res. 1989;32 Suppl 1:202-5. doi: 10.1159/000181346.
PMID:2533150
Abstract
In an open phase II, multicentre study with 118 pre- or perimenopausal women with histologically proven advanced breast cancer, Zoladex depot (3.6 mg) has been shown to produce an effective castration and response rates, which are comparable to those from oophorectomy.
摘要
在一项开放的II期多中心研究中，对118名组织学确诊为晚期乳腺癌的绝经前或围绝经期女性进行了研究，结果显示，戈舍瑞林长效注射剂（3.6毫克）可产生有效的去势效果和反应率，与卵巢切除术的效果相当。
Zotero 插件